MGRX stock news
This page provides real-time market news, earnings updates, and company announcements related to Mangoceuticals, Inc. (MGRX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-25 15:45 EST
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
Finviz2026-02-19 21:09:43
Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model
Finviz2026-02-20 15:00:39
Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
Finviz2026-02-23 21:09:11
MGRX stock chart
MGRX stock detailsMGRX stock price change
On the last trading day, MGRX stock closed at 0.40 USD, with a price change of 0.30% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more